Medline procedure kits labeled as: 1) ACOUSTIC NEUROMA PACK-LF, Pack Number DYNJ37741B; 2) ANGIOGRAPHY PACK, Pack Number DYNJ21519W; 3) NEURO ANGIO PACK, Pack Number DYNJ83941; 4) NEURO ANGIO PACK SJF-LF, Pack Number DYNJ55678; 5) NEURO PACK, Pack Number DYNJ04851Q; 6) SNI NEURO, Pack Number DYNJ45379D; 7) VP SHUNT PACK, Pack Number DYNJ55558C
This recall is currently active, issued March 26, 2025. It was issued by Medline Industries, Lp - Northfield.
- Recall Initiated
- February 11, 2025
- Posted
- March 26, 2025
- Recall Number
- Z-1464-2025
- Quantity
- 422
- Firm Location
- Northfield, IL
- Official Source
- View on FDA website ↗
Reason for Recall
Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/other quality issues have been identified that may pose a risk to patient health.
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Lot / Code Info
1) Pack Number DYNJ37741B: UDI/DI (each) 40193489682213 (case), Lot Number 20BDB113A; 2) Pack Number DYNJ21519W: UDI/DI (each) 40889942255611 (case), Lot Number 20BDB225A; 3) Pack Number DYNJ83941: UDI/DI (each) 40888277736574 (case), Lot Number 22JBA879Z; 4) Pack Number DYNJ55678: UDI/DI (each) 40193489468688 (case), Lot Number 22JBC551Z; 5) Pack Number DYNJ04851Q: UDI/DI (each) 40889942402176 (case), Lot Number 22JBC798Z; 6) Pack Number DYNJ45379D: UDI/DI (each) 40195327048748 (case), Lot Number 23FME560A; 7) Pack Number DYNJ55558C: UDI/DI (each) 40195327408214 (case), Lot Number 23LMG468A
Root Cause
Under Investigation by firm
Action Taken
Medline Industries LP issued a recall notice to its consignees on 02/11/2025 via letter delivered via USPS and email. The notice explained the issue, provided a link to for information pertaining to the risk involved https://www.fda.gov/medical-devices/safety-communications/update-evaluating-plastic-syringes-made-china-potential-device-failures-fda-safety-communication) and request the syringes within the convenience be discarded, except for circumstances where no alternative syringes are readily available. If these syringes must be used, closely monitor for leaks, breakage, and any other problems, and report any quality issues to Medline and the FDA. Distributors were directed to notify their customers.